February 3, 2020

National Stock Exchange of Limited BSE Limited Exchange Plaza, Corporate Relationship Department Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers Sandra Kurla Complex Dalal Street Sandra (E) Mumbai- 400001 Mumbai - 400 051

Sub: Intimation of Re-designation & Appointment of Directors and KMP.

Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR Regulations")

Dear Sir/Madam,

Please take note that, based on recommendations of Nomination and Remuneration Committee, the Board of Directors in their meeting held today i.e February 3, 2020, approved the following matters:

1. Re-designating (Hony) Brig. Dr. Arvind Lal by appointing him as Executive Chairman and Whole Time Director for a period of two (2) years, commencing from April 1, 2020 from his present designation of Chairman and Managing Director of the Company.

2. Re-designating Dr. Om Prakash Manchanda by appointing him as Managing Director for a period of five (5) years, commencing from April 1, 2020 from his present designation of CEO & Whole-Time Director of the Company.

3. Re-appointment of Dr. Vandana Lal as Whole-Time Director of the Company for a period of five (5) years, commencing from April 1, 2020.

4. Re-designating Mr. Bharath Uppiliappan by appointing him as Chief Executive Officer (CEO) and Key Managerial Personnel (KMP), commencing from April 1, 2020 from his present designation of CEO (India Business) of the Company.

Regd. Office:Dr. Lal P.ilhLaos I.Lt.,,. Siock E. Sc,."t,�r-lR Rohinl, New - i I OCSS. +91-1 1-302581-00. Fax: +91-11-2788 2134 Corporate Office: Dr. Lar Pdthlabs Ltd., ! 2th Flom. Tower 8, SAS Tower, Meuicity, S�or-38, G:.irugram - 122 00 I. H�ryana +91-124-3016-500. Fax: +9 l -124-4234-468 E-mail: la1patJ 1/dbi•�•ialratl dabs rom, Web: www.lalpaU1labs com, CIN No.: !.:'4=,'?OL 1 '195PLC0653S8 "I,_ The Re-designation/Re-appoi_ntment of (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal, is subject to approval of Shareholders of the Company.

Please also take note that (Hony) Brig. Dr. Arvind Lal, Dr. Om Prakash Manchanda and Dr. Vandana Lal are not debarred from holding the office of Director by virtue of any order of Securities and Exchange Board of India or any other such Authority.

Details as required under Regulation 30 of the SEBI LODR Regulations are a_ttached herewith as an Annexure A.

Thanking You, Yours Faithfully,

Rajat Kalra Company Secretary & Legal Head

Encl: As above

Medical College, . He After graduating from the IIMA in June University of Delhi. She has over He is an Electrical and has been conferred by the 1990, he was selected as a management 33 years of experience in the Electronics Engineer from President of India an Honorary trainee for Lipton India Limited now field of pathology. NIT Trichy and has a Brigadier's rank in the Armed amalgamated into PGDM from SP Jain Forces Medical Services and Limited ("HUL"}, under the management Dr. Vandana Lal is also trained in Institute of Management also the Padma Shri award. trainee scheme of Unilever Group of I Quality Assurance and & Research, Mumbai. In Companies in India. spearheads the quality I his 25 year career so far, He has over 43 years of implementation process in all the he has been focused on experience in the field of He has worked with HUL in various laboratories of Dr Lal PathLabs . building brands and Pathology and is recognized positions such as Area Manager, She is the head of Clinical businesses across start­ as a pioneer in bringing Innovation Manager -Beverages, Research Services being the up, growth and laboratory services in India at Business Manager - Loose Tea, Chief Technical Officer since turnaround phases with par with the western world. Brookfields and Senior Product Manager. 2007, playing a pivotal role in industry leading Under his expertguidance and In HUL as a Senior Product Manager - conception, planning, companies viz. FMCG leadership, Dr. Lal Innovation, he spearheaded the construction, execution & (Hindustan. Unilever Ltd}, PathLabs has become one of execution of Tea Based Beverage operationalizing the Clinical trials Retailing (Bharti Walmart the most reputed laboratories development project under the brand division. She also heads the - Bharti Retail Ltd) in Asia, name of Lipton Tiger. This innovation Research & Development wing Telecom ( went on to win many awards viz., Unilever of Dr Lal PathLabs by monitoring Ltd.) in multiple He brought International I Central Asia and Mi_ddle East ("CAME") I development of new tests and categories like· Foods, recognition to the Indian Best Marketable Idea of the Year Award I methods. Apparel, Home, Personal Healthcare Industry in the I in 1997, CAME Innovation Award for Best Care, General form of accreditation from the I Proven Initiative of the Year in 1998 and I She is the Executive Director of I Merchandise and telecom College of American Unilever Foods Innovation Award in Dr. Lal PathLabs since 1995. across both "India and Pathologists (CAP - USA). Beverages Category in the year 1999. Her job profile includes Bharat" expansion of activities of the �_,..., laboratory with assistance in ((] \ -.J' ;· , <.)- ·-,